LENZ — LENZ THERAPEUTICS INC

Ownership history in US BANCORP \DE\  ·  3 quarters on record

This page tracks every 13F SEC filing in which US BANCORP \DE\ reported a position in LENZ THERAPEUTICS INC (LENZ). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 9 -66 -88.0% 0.00% $419 $46.58
2025 Q1 REDUCED 75 -41 -35.3% 0.00% $2K $25.71
2024 Q4 INITIATED 116 — — 0.00% $3K $28.87
% of Fund (quarterly)    LENZ price (monthly, adj. close)

Other funds also holding LENZ

As of 2025 Q4 — sorted by position size

72 Investment Holdings, LLC 3Y 32.2% Versant Venture Management, LLC 3Y 7Y 28.14% Alpha Wave Global, LP 3Y 7Y 7.08% Intrinsic Edge Capital Management LLC 3Y 7Y 1.62% PLUSTICK MANAGEMENT LLC 3Y 1.42% Propel Bio Management, LLC 0.81% RA CAPITAL MANAGEMENT, L.P. 3Y 7Y 0.68% TANG CAPITAL MANAGEMENT LLC 3Y 7Y 0.68% SECTORAL ASSET MANAGEMENT INC 3Y 7Y 0.55% Knott David M Jr 3Y 0.4%
← Back to US BANCORP \DE\ Holdings